The cutting-edge weight-loss drug Ozempic/Wegovy can stop ... seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

Ozempic is becoming popular among diabetics and people who want to lose weight. But it has a few side effects, including ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop ... seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

The combination of avutometinib and defactinib is the first FDA-approved treatment for KRAS-mutated ... each for 3 weeks of a 4-week cycle until disease progression or intolerable toxicity.

Novartis has a third FDA-approved indication ... a green light in ultra-rare kidney disease C3 glomerulopathy (C3G). Fabhalta (iptacopan) is the first treatment approved for C3G, which mostly ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease ... which was approved to treat CKD patients earlier this year by the FDA, adding to an ...

Parkinson’s disease is the most ... can help manage symptoms, but treatment benefits often diminish or become less consistent over time. The FDA recently approved a treatment that offers a ...

Ozempic is used to help control blood sugar levels in adults with type 2 diabetes. It is also used to lower the risk of major heart events in people with both type 2 diabetes and heart disease, such ...